Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Controlled Study of EXPAREL for Postsurgical Pain Management in Subjects Undergoing Open Lumbar Spinal Fusion Surgery
Conditions
Interventions
EXPAREL and bupivacaine HCl
Bupivacaine HCl
Locations
15
United States
OrthoArizona
Gilbert, Arizona, United States
St. Joseph's Hospital
Phoenix, Arizona, United States
UC Davis
Sacramento, California, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Beaumont Health
Troy, Michigan, United States
Washington Univ
St Louis, Missouri, United States
Start Date
February 21, 2017
Primary Completion Date
October 30, 2017
Completion Date
October 30, 2017
Last Updated
October 13, 2021
NCT07327463
NCT07186426
NCT07231926
NCT07145619
NCT07232108
NCT07113483
Lead Sponsor
Pacira Pharmaceuticals, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions